What Is Chronic Spontaneous Urticaria?
Chronic Spontaneous Urticaria (CSU) is a subtype of chronic urticaria in which recurring hives — raised, itchy welts on the skin — occur for six weeks or longer with no identifiable external trigger. This is what makes CSU distinct from other forms of chronic hives: the welts appear spontaneously, not in response to cold, pressure, exercise, or any other physical stimulus.
CSU was previously known as chronic idiopathic urticaria (CIU) — a term still used by some patients and providers. While the two terms are often used interchangeably in practice, current international guidelines (EAACI/GA²LEN/EDF) prefer “chronic spontaneous urticaria” as it more accurately reflects what is known about the condition’s autoimmune and immune-mediated mechanisms.
CSU is not a life-threatening condition in most cases, but it significantly impacts quality of life. The unpredictability of flares — combined with persistent itch, sleep disruption, and the visible nature of the rash — can take a real toll on daily functioning and emotional wellbeing.
CSU vs. Chronic Inducible Urticaria Chronic urticaria has two main subtypes. CSU occurs without a specific trigger. Chronic Inducible Urticaria (CIndU) is triggered by identifiable physical stimuli — such as cold, heat, pressure, or sunlight. Some patients have both. Dermatographia (skin-writing hives from friction) is a common form of CIndU that we also treat.
Symptoms of Chronic Spontaneous Urticaria
CSU symptoms can vary in severity from day to day and week to week. The defining feature is hives that appear repeatedly over six weeks or more, without a consistent external cause. Individual welts typically resolve within 24 hours at one site, only to reappear elsewhere on the body.
Raised Welts (Wheals) Red, pink, or flesh-colored bumps or patches, clearly elevated from surrounding skin. Can range from a few millimeters to several centimeters.
Intense Itching Often described as burning or maddening. Itching is typically worse at night and can severely disrupt sleep.
Migrating Location Welts fade from one area and re-emerge elsewhere — they appear to move across the body over hours or days.
Angioedema Deeper swelling under the skin, occurring in roughly 40–50% of CSU patients. Common around the eyes, lips, hands, and feet. Learn more about angioedema.
Sleep & Fatigue Nighttime itching causes chronic sleep disruption, leading to fatigue and difficulty concentrating during the day.
Emotional Impact Anxiety, depression, and reduced quality of life are common — particularly when CSU is uncontrolled or undiagnosed.
⚠ Seek Emergency Care Immediately If: Hives are accompanied by throat tightening, difficulty breathing, dizziness, or facial swelling. These may indicate anaphylaxis, a life-threatening emergency. Call 911 or go to the nearest emergency room.
What Causes Chronic Spontaneous Urticaria?
In CSU, mast cells in the skin release histamine and other inflammatory chemicals without an identifiable external cause. In approximately 30–50% of cases, this occurs due to an autoimmune mechanism — the immune system produces antibodies (typically IgE or IgG) that activate mast cells directly. In the remaining cases, the precise trigger remains unclear even after thorough evaluation.
CSU has also been associated with thyroid disease, other autoimmune conditions, and — in some cases — chronic infections such as H. pylori. Your allergist will screen for these when appropriate.
While CSU hives arise spontaneously, certain factors are known to worsen or provoke flares in people who already have the condition. These are called aggravating factors rather than root causes:
- Emotional or physical stress
- NSAIDs (aspirin, ibuprofen)
- ACE inhibitor medications
- Alcohol
- Fever or infection
- Hormonal changes
- Overheating
- Tight clothing
- Exercise
- Histamine-rich foods
- Food additives (e.g., benzoates)
A note on food allergies Food allergies are rarely a root cause of CSU. Extensive elimination diets are generally not recommended without guidance, as they can cause nutritional deficiencies without meaningfully improving hives. If you suspect a specific food worsens your symptoms, keep a diary and discuss it with your allergist.
How Is CSU Diagnosed?
There is no single test that confirms CSU. Diagnosis is primarily clinical — based on your medical history, the pattern of your hives, and the careful exclusion of other causes. A board-certified allergist is the most appropriate specialist to evaluate and manage CSU.
What to expect at your appointment Your allergist will ask about when the hives started, how often they appear, how long individual welts last, what makes them better or worse, and what treatments you’ve tried. Take photos of hives during a flare — they often resolve before you reach the office.
Diagnostic testing Your provider will order targeted lab work to rule out underlying conditions. This typically includes a complete blood count (CBC), inflammatory markers (CRP, ESR), and thyroid function tests. Screening for autoimmune conditions or chronic infections may also be warranted based on your history.
Standard allergy skin testing and food allergy panels are generally not helpful for diagnosing CSU, as the condition is not driven by IgE-mediated allergic reactions to specific allergens.
Urticaria Activity Score (UAS7) Your allergist may use the Urticaria Activity Score (UAS7) — a validated 7-day diary where you track the number of hives and severity of itch each day. This tool helps measure disease severity and monitor how well treatment is working over time.
Treatment Options for CSU
The goal of treatment is complete symptom control — no hives, no itch — with the least side effects possible. Treatment follows a stepwise approach based on international urticaria guidelines, and the majority of patients can achieve excellent control with modern therapies.
Step 1: Second-Generation Antihistamines (First-Line) Non-drowsy antihistamines — cetirizine (Zyrtec), loratadine (Claritin), or fexofenadine (Allegra) — are the foundation of CSU treatment. They should be taken daily, not just during flares, and doses may be increased up to four times the standard amount if needed. These are safe for long-term use.
Step 2: Optimized Antihistamine Dosing If standard doses don’t provide adequate relief, your allergist may increase the dose or combine antihistamines. The addition of an H2 blocker (such as famotidine) may provide additional benefit in some patients.
Step 3: Biologic Therapy
For patients who don’t respond adequately to antihistamines, biologic medications represent a major breakthrough in CSU care. These are highly effective, targeted therapies with excellent safety profiles.
Omalizumab (Xolair) — The first-line biologic for CSU. This FDA-approved medication is given as a subcutaneous injection once monthly. It works by binding to free IgE, dampening the cascade that activates mast cells. The majority of patients experience significant or complete relief of hives, typically within weeks to months of starting treatment.
Dupilumab (Dupixent) — A newer biologic option FDA-approved for CSU in patients 12 years and older who remain inadequately controlled on H1 antihistamines. Dupixent targets IL-4 and IL-13, key inflammatory pathways involved in CSU. It is administered as a subcutaneous injection every two weeks and has shown significant efficacy in reducing hive activity and itch in clinical trials.
The goal of treatment is complete symptom control — no hives, no itch — with the least side effects possible. Treatment follows a stepwise approach based on international urticaria guidelines, and the majority of patients can achieve excellent control with modern therapies.
Step 1: Second-Generation Antihistamines (First-Line) Non-drowsy antihistamines — cetirizine (Zyrtec), loratadine (Claritin), or fexofenadine (Allegra) — are the foundation of CSU treatment. They should be taken daily, not just during flares, and doses may be increased up to four times the standard amount if needed. These are safe for long-term use.
Step 2: Optimized Antihistamine Dosing If standard doses don’t provide adequate relief, your allergist may increase the dose or combine antihistamines. The addition of an H2 blocker (such as famotidine) may provide additional benefit in some patients.
Step 3: Biologic Therapy
For patients who don’t respond adequately to antihistamines, biologic medications represent a major breakthrough in CSU care. These are highly effective, targeted therapies with excellent safety profiles.
Omalizumab (Xolair) — The first-line biologic for CSU. This FDA-approved medication is given as a subcutaneous injection once monthly. It works by binding to free IgE, dampening the cascade that activates mast cells. The majority of patients experience significant or complete relief of hives, typically within weeks to months of starting treatment.
Dupilumab (Dupixent) — A newer biologic option FDA-approved for CSU in patients 12 years and older who remain inadequately controlled on H1 antihistamines. Dupixent targets IL-4 and IL-13, key inflammatory pathways involved in CSU. It is administered as a subcutaneous injection every two weeks and has shown significant efficacy in reducing hive activity and itch in clinical trials.
Remibrutinib (Rhapsido) — The newest FDA-approved treatment for CSU, approved in 2025. Remibrutinib is an oral medication (taken once daily as a pill) that works by blocking BTK (Bruton’s tyrosine kinase), a key enzyme in the pathway that activates mast cells and basophils. This represents the first oral targeted therapy for CSU and offers an alternative for patients who prefer not to use injections or who have not responded to other biologics.
Step 4: Immunosuppressants (Refractory CSU) A small number of patients with CSU that does not respond to the above steps may require additional agents such as cyclosporine or mycophenolate mofetil. These require close monitoring and are used selectively. Additional biologic agents and novel therapies are also being evaluated in ongoing clinical trials.
⚠ Note on Oral Corticosteroids Prednisone can rapidly calm a severe flare but is not appropriate for long-term CSU management due to significant side effects with extended use. It may be used short-term during an acute episode but should not serve as a primary or ongoing treatment.
Living with Chronic Spontaneous Urticaria
Medication is only part of the picture. Day-to-day strategies can meaningfully reduce flare frequency and protect your quality of life — especially on the harder days.
Keep a Symptom Diary Log when flares occur, what you ate, your stress level, sleep, and activity. Patterns help you and your allergist identify personal aggravating factors.
Take Medication Consistently Antihistamines work best when taken on a regular schedule. Daily dosing — even on symptom-free days — maintains a protective baseline in your system.
Minimize Known Aggravators Avoid very hot showers, overheating, alcohol, and NSAIDs where possible. Opt for loose, breathable clothing and cool environments when symptoms are active.
Soothe Actively Cool compresses on wheals provide immediate itch relief. Use gentle, fragrance-free moisturizers. Avoid scratching — it worsens inflammation and can trigger new wheals.
Manage Stress Stress is one of the most common flare triggers. Mindfulness, yoga, regular exercise at a comfortable intensity, and good sleep hygiene all contribute to better disease control.
Regular Follow-Up CSU evolves over time. Ongoing appointments with your allergist ensure your treatment plan is adjusted as needed — and help identify when remission may be occurring.
It’s also important to acknowledge the emotional toll of CSU. Anxiety about the next flare, embarrassment about visible hives, and frustration with an unpredictable condition are all common and completely valid. If you’re struggling emotionally, speaking with a therapist experienced in chronic illness can make a meaningful difference. Don’t hesitate to raise this with your care team.
Frequently Asked Questions About CSU
What is the difference between CSU and CIU? “Chronic idiopathic urticaria” (CIU) was an older term used when no cause could be identified. Current international guidelines now use “chronic spontaneous urticaria” (CSU) to reflect that the condition has identifiable immune mechanisms even when a specific trigger cannot be found. The two terms refer to essentially the same condition, and many providers still use CIU — so you may hear both. Confusingly, “CIndU” (chronic inducible urticaria) is a different and separate subtype involving physical triggers.
Will CSU go away on its own? For many patients, yes — CSU does eventually go into remission. Research suggests that roughly 50% of patients experience spontaneous remission within one year, and the majority within 5 years. However, some patients experience a longer course. This variability is why consistent treatment and regular follow-up with your allergist are important throughout.
Is CSU caused by food allergies? Rarely. Food allergies are not typically the root cause of CSU. Some substances — particularly alcohol, spicy foods, and histamine-rich foods like aged cheeses or processed meats — can worsen symptoms in some patients, but they don’t cause the underlying condition. Broad elimination diets without clear evidence of food-related triggers are generally not recommended.
What biologic treatments are available for CSU? There are now three FDA-approved biologic therapies for CSU. Omalizumab (Xolair) is typically the first biologic used — it’s given monthly by injection and works by binding to IgE. Dupilumab (Dupixent) is a newer option that targets IL-4 and IL-13 pathways and is given every two weeks by injection. Remibrutinib (Rhapsido), approved in 2025, is the first oral medication specifically targeting CSU — it blocks BTK, a key enzyme in mast cell activation, and is taken once daily as a pill. Your allergist will help determine which treatment is most appropriate based on your individual case, insurance coverage, and preferences.
How does Xolair (omalizumab) work for CSU? Omalizumab (Xolair) is a monoclonal antibody that binds to free IgE in the bloodstream, reducing its ability to sensitize mast cells. With fewer sensitized mast cells, the inflammatory cascade that causes hives is significantly dampened. It is FDA-approved for CSU in patients who remain symptomatic on antihistamines. The monthly in-office injection is well tolerated, and many patients see significant improvement within weeks. It suppresses CSU while in use but is not a permanent cure.
How does Dupilumab (Dupixent) work for CSU? Dupilumab (Dupixent) is a monoclonal antibody that blocks the interleukin-4 (IL-4) and interleukin-13 (IL-13) receptors, two key proteins involved in type 2 inflammation. In CSU, blocking these pathways reduces the inflammatory signals that contribute to mast cell activation and hive formation. Dupixent is given as a subcutaneous injection every two weeks and is FDA-approved for patients 12 years and older with CSU who remain inadequately controlled on antihistamines. Clinical trials have shown significant reductions in hive activity, itch severity, and improved quality of life. Like omalizumab, it suppresses CSU while in use but does not cure the underlying condition.
How does Remibrutinib (Rhapsido) work for CSU? Remibrutinib (Rhapsido) is an oral medication that works by inhibiting Bruton’s tyrosine kinase (BTK), an enzyme that plays a critical role in the signaling pathways of mast cells and basophils — the immune cells responsible for releasing histamine in CSU. By blocking BTK, remibrutinib prevents these cells from being activated and releasing the inflammatory chemicals that cause hives and itching. It is taken once daily as a pill, making it the first oral targeted therapy specifically approved for CSU. Remibrutinib was FDA-approved in 2025 and offers an alternative for patients who prefer oral medication over injections or who have not responded adequately to other biologic therapies.
Can I take Benadryl for my chronic hives? Benadryl (diphenhydramine) can relieve itch in a pinch, but it’s not recommended for routine CSU management. It causes significant drowsiness, impairs driving and cognitive function, and wears off quickly — making it poorly suited for a condition requiring consistent daily treatment. Second-generation antihistamines like cetirizine, loratadine, or fexofenadine are far more appropriate for ongoing use.
When should I see an allergist for my hives? If you’ve had recurring hives for more than six weeks, or if over-the-counter antihistamines aren’t controlling your symptoms, it’s time to see a board-certified allergist. A specialist can confirm the diagnosis, rule out underlying causes, and build a personalized treatment plan — including access to advanced therapies like omalizumab, dupilumab, and remibrutinib that are not available without a prescription.
Get Expert Care for Chronic Hives in New York
Our allergists specialize in diagnosing and treating Chronic Spontaneous Urticaria at locations across NYC. Call (212) 686-6321 to book an appointment online today.
